- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daewon Pharm (003220)
Daewon Pharm stock price live, this page displays KS 003220 stock exchange data. View the 003220 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Daewon Pharm real time stock price chart below.
What Is the Daewon Pharm Stock Price Today?
The Daewon Pharm stock price today is 13,190.
What Is the Stock Symbol for Daewon Pharm?
The stock symbol for Daewon Pharm is ""003220.""
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003220 quote. (ISIN: KR7003220001)
What Is the Daewon Pharm Stock Price Today?
The Daewon Pharm stock price today is 13,190.
What Is the Stock Symbol for Daewon Pharm?
The stock symbol for Daewon Pharm is ""003220.""
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003220 quote. (ISIN: KR7003220001)
Seoul
Currency in KRW
13,190
+140(+1.07%)
Delayed Data·
Fair Value
An estimate of a Daewon Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13,090
13,200
52 wk Range
12,370
17,890
003220 Scorecard
Full Analysis
Stock generally trades with low price volatility
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a Daewon Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13,09013,200
52 wk Range
12,37017,890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003220 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Daewon Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
19,000
Upside
+44.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Daewon Pharm Company Profile
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Compare 003220 to Peers and Sector
Metrics to compare | 003220 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003220PeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.6x | 7.5x | −0.5x | |
PEG Ratio | −0.44 | 0.02 | 0.00 | |
Price/Book | 1.0x | 0.8x | 2.6x | |
Price / LTM Sales | 0.5x | 0.7x | 3.3x | |
Upside (Analyst Target) | 45.6% | 57.3% | 42.9% | |
Fair Value Upside | Unlock | 25.6% | 6.2% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 19,000
(+44.05% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
251.00 / --
Revenue / Forecast
157.80B / 133.50B
FAQ
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for Daewon Pharm?
The stock symbol for Daewon Pharm is "003220."
What Is the Daewon Pharm Market Cap?
As of today, Daewon Pharm market cap is 279.71B.
What Is Daewon Pharm's Earnings Per Share (TTM)?
The Daewon Pharm EPS (TTM) is 536.93.
When Is the Next Daewon Pharm Earnings Date?
Daewon Pharm will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is 003220 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Daewon Pharm Stock Split?
Daewon Pharm has split 17 times.
How Many Employees Does Daewon Pharm Have?
Daewon Pharm has 1283 employees.
What is the current trading status of Daewon Pharm (003220)?
As of 12 Aug 2025, Daewon Pharm (003220) is trading at a price of 13,190.00, with a previous close of 13,050.00. The stock has fluctuated within a day range of 13,090.00 to 13,200.00, while its 52-week range spans from 12,370.00 to 17,890.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.